Kathryn Phillips, PhD
|School||UCSF School of Pharmacy|
|Address||3333 Calif. St,Laurel Heights |
San Francisco CA 94143
Kathryn A. Phillips PhD is Professor of Health Economics and Health Services Research at the University of California, San Francisco (UCSF) and Founder/Director of the UCSF Center for Translational and Policy Research on Personalized Medicine (TRANSPERS). She has appointments in the UCSF Department of Clinical Pharmacy (primary), the UCSF Institute for Health Policy Studies, and the UCSF Comprehensive Cancer Center. Dr. Phillips holds degrees from the University of California-Berkeley, Harvard, and the University of Texas at Austin and previously spent eight years working for the federal government.
Dr. Phillips’ research focuses on using quantitative tools to examine policy issues on how health care is organized, delivered, and financed in the US. Her emphasis is on translation of new technologies and personalized medicine – targeting health care interventions to patients based on their genetics – and its impact on clinical care, health economics, and health policy. Dr. Phillips is the Principal Investigator for the TRANSPERS Center, which is a multi-million dollar effort focusing on the translation of personalized medicine into practice and policy. TRANSPERS has been supported by the National Institutes of Health and several other organizations and foundations. She has published over 100 peer-reviewed articles in leading journals (e.g., JAMA, New England Journal of Medicine, Health Affairs), serves on the editorial board for seven journals including Health Affairs (a preeminent policy journal), and has led or participated in approximately 50 funded research grants, with continuous funding from the NIH as a Principal Investigator since 1993.
Dr. Phillips conducts cross-disciplinary research across the basic, clinical, and social sciences and cross-sector research across academia, industry, and government. She has served as an adviser to many organizations (e.g., Institute of Medicine, President’s Council of Advisors on Science and Technology, GenomeCanada, FDA, Australia Pharmaceutical Benefits and Medicare Services Advisory Committees) and regularly speaks to national and international groups. A unique role is her leadership of the TRANSPERS Reimbursement Policy Board, which includes senior executives from the seven largest US health plans, leading regional plans, and pharmacy benefits management companies as well as thought leaders with industry, government, and Medicare perspectives. Dr. Phillips also consults with a number of biotech start-ups, companies, and venture capital firms.
Click the "See All" links for more information and interactive visualizations!
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share similar concepts with this person.